Emergent BioSolutions Inc. signed a five-year agreement with Calgary-based biotechnology company Providence Therapeutics to develop and manufacture its COVID-19 vaccine candidate for about $90 million.
More...
From
http://start.westnet.ca News
News Provided By
WestNet Wireless Internet